(2025). Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025. MMWR Morbidity and Mortality Weekly Report.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025."
MMWR Morbidity and Mortality Weekly Report 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025."
MMWR Morbidity and Mortality Weekly Report, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.